- Home
- PLSE vs AB Comparison
PLSE vs AB Comparison
Compare PLSE & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLSE | AB |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PLSE | AB |
|---|---|---|
| Price | $47.02 | $36.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $22.00 | ★ $40.40 |
| AVG Volume (30 Days) | ★ 453.4K | 260.0K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 8.59% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | N/A |
| Revenue Next Year | $287.54 | $6.45 |
| P/E Ratio | ★ N/A | $13.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $34.92 |
| 52 Week High | $48.10 | $44.11 |
Technical Indicators
Market Signals| Indicator | PLSE | AB |
|---|---|---|
| Relative Strength Index (RSI) | 78.25 | 44.35 |
| Support Level | $24.27 | $35.96 |
| Resistance Level | N/A | $39.60 |
| Average True Range (ATR) | 3.09 | 0.54 |
| MACD | 0.62 | -0.09 |
| Stochastic Oscillator | 98.50 | 39.85 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of February 2026, the company had $880.0 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (40%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.